Home/TeamedOn/Peter Mu, PhD, MBA
PM

Peter Mu, PhD, MBA

President and CEO

TeamedOn

TeamedOn Pipeline

DrugIndicationPhase
XLRS Gene TherapyX-linked RetinoschisisPre-clinical